Brave New World trailer (see below) - unveiled at the inaugural Brazil D23 fan event - teases national mayhem as Anthony Mackie’s Sam Wilson takes up the mantle of the titular superhero. Premiering ...

Brave New World. The trailer, unveiled at D23 Brasil, reveals the best look yet at Harrison Ford as Red Hulk, teasing the big ...

The third installment — and allegedly the last — focusing on the Marvel Comics characters leans ... the lowest opening of the three “Venom” films and a steep drop from when “Venom ...

Eagle-eyed fans have spotted a trans flag in the final two episodes of Agatha All Along – and Joe Locke had something to do ...

Agatha All Along finished just before Halloween, giving us an open-ended wrap up to the series that hinted we have not seen ...

Located in the heart of Milwaukee, Riverview Antique Market stands as a beacon for treasure hunters and nostalgia enthusiasts ...

Two novel peptides derived from Protagonist's proprietary discovery platform are in advanced Phase 3 clinical development, with potential New Drug Application submissions to the FDA in 2025.

Myeloproliferative Syndromes: Clinical and Epidemiological: Poster III Session Date ... proprietary discovery platform are in advanced Phase 3 clinical development, with potential New Drug ...

Agios expects to report topline results from this 52-week Phase 3 study in late 2025. Sickle cell disease is an inherited, lifelong blood disorder caused by mutations in hemoglobin, the major ...

The FDA has implemented a partial hold on a phase 3 non-small cell lung cancer trial run by BioNTech and OncoC4 after seeing varying results among patients. The hold impacts an open-label trial ...

The coming months may be interesting as the company moves closer to Phase 3 data. Analyst target of $15 implies over 1,000% upside; I maintain a Buy rating despite near-term financing ...